Evidence map›Paper›PMID 23478809›Full record

ArticleJournal of biomedical optics2013

Advantages of full spectrum flow cytometry.

Claire K Sanders, Judith R Mourant

Open access · hybridAbstract read
In one paragraph

Article in Journal of biomedical optics, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.0field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 29 citations in OpenAlex.

  1. Guidelines for Gating Flow Cytometry Data for Immunological Assays.Methods in molecular biology (Clifton, N.J.) · 2027
    Article
  2. Article
  3. Development of Spectral Imaging Cytometry.Methods in molecular biology (Clifton, N.J.) · 2023
    Review
  4. Article
  5. Article
  6. Article
  7. Full spectrum flow cytometry and mass cytometry: A 32-marker panel comparison.Cytometry. Part A : the journal of the International Society for Analytical Cytology · 2022
    Article
  8. Review
  9. Review
  10. OMIP-069: Forty-Color Full Spectrum Flow Cytometry Panel for Deep Immunophenotyping of Major Cell Subsets in Human Peripheral Blood.Cytometry. Part A : the journal of the International Society for Analytical Cytology · 2020
    Article
  11. Article
  12. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Claire K SandersBioscience Division, Los Alamos National Laboratory, P.O. Box 1663, MS M888, Los Alamos, New Mexico 87544, USA. csanders@lanl.gov
Judith R Mourant
Los Alamos National Laboratory · US

Funding

WORKSHOP AT INTERNATIONAL SOCIETY FOR ANALYTICAL CYTOLOGYP41RR001315 · NCRR · UNIVERSITY OF CALIF-LOS ALAMOS NAT LAB · PI DOORN, JONATHAN A · 1985 to 2011
$19.2M
LIGHT SCATTERING IN TUMOR AND NORMAL TISSUE MODELSR01CA071898 · NCI · UNIVERSITY OF CALIF-LOS ALAMOS NAT LAB · PI MOURANT, JUDITH R · 1997 to 2012
$7.7M
NCI NIH HHS CA071898NCI NIH HHS R01 CA071898NCRR NIH HHS P41 RR001315NCRR NIH HHS P41-RR01315
6 · The paper itself

Abstract

A charge coupled device-based flow-cytometer for the measurement of full spectra was implemented and characterized. The spectral resolution was better than 1.5 nm and the coefficient of variation for fluorescence from flow check beads was 5% or better. Both cell and bead data were analyzed by fitting to measured component spectra. Separation of flow check and align flow beads, which have similar spectra, was nearly identical whether using a spectral analysis or a scatter analysis. After mixing, cells stained with ethidium bromide or propidium iodide were measured at different timepoints. The contribution of these 12 nm separated emission spectra could be separately quantified and the kinetic process of the samples becoming homogeneous due to fluorophor dissociation and rebinding was observed. Principle component analysis was used to reduce noise and alternating least squares (ALS) was used to analyze one set of noise-reduced cell data without knowledge of the component spectra. The component spectra obtained via ALS are very similar to the measured component spectra. The contributions of ethidium bromide and propidium iodide to the individual spectra are also similar to those obtained via the spectral fitting procedure.

Indexed as

AnimalsCell Line, TumorEthidiumFlow CytometryFluorescent DyesLeast-Squares AnalysisPolystyrenesPrincipal Component AnalysisPropidiumRatsEthidiumFluorescent DyesPolystyrenesPropidium

Identifiers

PMID23478809
PMCPMC3592788
OpenAlexW2043076395

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.